IDQoL, CDLQI and the 45‐item CADIS received a sufficient content validity rating during the HOME VII meeting in Japan: a group discussion study

URN to cite this document:: urn:nbn:de:bvb:355-epub-506490
DOI to cite this document:: 10.5283/epub.50649

Gabes, M.

; Apfelbacher, C.

License: Creative Commons Attribution Non-commercial No Derivatives 4.0
PDF - Published Version
(140kB)

Date of publication of this fulltext: 11 Oct 2021 13:10

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background The Harmonising Outcome Measures for Eczema (HOME) initiative has agreed that quality of life should be measured in all atopic eczema clinical trials. Various candidate instruments exist for this domain but their content validity in atopic eczema is largely unclear. Objective To assess the content validity of quality-of-life candidate instruments for atopic eczema in infants, children ...